Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice
Praveen Bathini, Stephan Schilling, Jens‐Ulrich Rahfeld, David M. Holtzman, Takaomi C. Saido, Cynthia Ann Lemere
This study investigates how early binding of anti-amyloid antibodies to cerebral amyloid angiopathy (CAA) drives complement activation, inflammation, and ARIA in Alzheimer's disease mouse models.
Molecular Neurodegeneration · Jun 26, 2026Peer-reviewedNeuroscience